デフォルト表紙
市場調査レポート
商品コード
1473990

臨床試験支援サービスの世界市場規模、シェア、成長分析、フェーズ別、適応症別 - 産業予測、2024~2031年

Global Clinical Trials Support Services Market Size, Share, Growth Analysis, By Phase(phases I, II), By Indication(Autoimmune/Inflammation, Oncology) - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 219 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.74円
臨床試験支援サービスの世界市場規模、シェア、成長分析、フェーズ別、適応症別 - 産業予測、2024~2031年
出版日: 2024年04月29日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の臨床試験支援サービスの市場規模は、2022年に208億6,000万米ドルとなり、予測期間中(2024~2031年)のCAGRは7.50%で、2023年の224億2,000万米ドルから、2031年までには399億9,000万米ドルに成長する見通しです。

臨床試験支援サービス、アッセイ設計、臨床試験はいずれも非常に有益です。また、キットの管理、薬剤投与量の計算、臨床試験サイトの保護、研究用医薬品の確保と保管も含まれます。前臨床の基礎と研究は臨床試験支援サービスによって提供され、臨床試験施設の支援、試験薬の入手と保管、試験薬の盲検化、患者の募集、調整、返送された医薬品の調整なども含まれます。臨床試験部門は2021年に大きな変革を遂げました。COVID-19予防接種の開発に伴い、パンデミックのために延期されていた多くの臨床試験が再開されました。臨床試験は、治療のための新薬を創出するために必要であり、この点では未実施の要望が多いからです。発展途上国は感染症、慢性疾患、熱帯病の罹患率が高いからです。バーチャル臨床試験の活用は、パンデミック後の業界の臨床試験支援サービス部門の収益拡大の大きな要因となっています。臨床研究サービスを効率化するため、バーチャル技術の活用に注力する臨床研究企業が増えています。

目次

エグゼクティブサマリー

  • 市場概要
  • 運命の輪

調査手法

  • 情報調達
  • 二次・一次情報源
  • 市場規模の推定
  • 市場の前提条件と制限

親市場の分析

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題

主要な市場の考察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料の分析
  • イノベーションマトリクス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主要な投資の分析
  • 主要な成功要因
  • 競合の程度

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • 規制情勢
  • ポーターの分析
  • 将来の混乱についての特別な考察

臨床試験支援サービスの世界市場:フェーズ別

  • 市場概要
  • フェーズI
  • IV

臨床試験支援サービスの世界市場:適応症別

  • 市場概要
  • 自己免疫 / 炎症
  • 腫瘍学
  • 糖尿病
  • 心臓血管

臨床試験支援サービスの世界市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主要な市場企業が採用した戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • IQVIA Holdings Inc.
  • PAREXEL International Corporation(a subsidiary of Pamplona Capital Management)
  • Charles River Laboratories International Inc.
  • PRA Health Sciences Inc.
  • ICON Plc
  • Syneos Health Inc.
  • Pharmaceutical Product Development LLC(PPD)
  • Wuxi AppTec Inc.
  • Medpace Holdings Inc.
  • SGS SA
  • Covance Inc.(a subsidiary of LabCorp)
  • Celerion Inc.
  • Clinipace Worldwide
  • Worldwide Clinical Trials Inc.
  • Novotech Pty Ltd.
  • MMS Holdings Inc.
  • Premier Research Group Ltd.
  • Medidata Solutions Inc.
  • Anavex Life Sciences Corp.
  • Cromsource Srl
目次
Product Code: SQMIG35D2068

Global Clinical Trials Support Services Market size was valued at USD 20.86 billion in 2022 and is poised to grow from USD 22.42 billion in 2023 to USD 39.99 billion by 2031, at a CAGR of 7.50% during the forecast period (2024-2031).

Clinical trial support services, assay design, and clinical testing are all highly beneficial. It also involves maintaining kits, calculating drug dosages, protecting clinical test sites, and securing and storing research drugs. Preclinical foundation and research are provided by clinical test support services, which also include assistance with clinical test sites, obtaining and storing study medicines, blinding study drugs, recruiting patients, coordinating, and reconciling returned pharmaceuticals. The clinical trial sector saw substantial transformation in 2021. As COVID-19 vaccinations were developed, many clinical trials that had been delayed due to the pandemic were reopened. Clinical trials are required in order to create novel medications for therapy, as there are many unfulfilled requests in this regard. This is because developing countries have higher rates of infectious, chronic, and tropical diseases. The utilization of virtual clinical trials has been a major factor in the post-pandemic revenue expansion of the industry's clinical trials support services sector. A growing number of clinical research companies are focusing on the use of virtual technologies to streamline their clinical research services.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trials Support Services Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trials Support Services Market Segmental Analysis

The clinical trials support market is segmented into phases, indication and sponsor. The Clinical Trials Support Services Market is divided into four phases: phases I, II, III, and IV. The Clinical Trials Support Services Market is divided into categories for autoimmune/inflammation, oncology, diabetes, cardiovascular, and others based on indication. The Clinical Trials Support Services Market is divided into pharmaceutical and biopharmaceutical businesses, medical device companies, and other companies based on the sponsor. Based on Region Clinical Trials Support Services Market is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Drivers of the Global Clinical Trials Support Services Market

The primary drivers of the market's growth include the increased prevalence of infectious and chronic diseases, pharmaceutical companies' large R&D expenditures, the rise of contract research organizations, and the need for clinical trials in developing nations.

Restraints in the Global Clinical Trials Support Services Market

The absence of advanced medical technology and infrastructure is impeding the market's growth. Rigid patient recruiting policies and insufficient trial management frameworks are further major barriers impeding the overall growth of the global clinical trial support services market. Nevertheless, the globalization of clinical trials and the evolution of technology brought about by continuous research and development present a profitable opportunity.

Market Trends of the Global Clinical Trials Support Services Market

The growing need for trials in developing countries, increased investment in research and development, and an increase in the quantity of contract research organizations are all indicators of the global market's rapid expansion (CROs). The pharmaceutical corporations have been increasing their research and development (R&D) investment annually, primarily due to the expiration of patents.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Clinical Trials Support Services Market by Phase

  • Market Overview
  • phases I
  • II
  • III
  • and IV

Global Clinical Trials Support Services Market by Indication

  • Market Overview
  • Autoimmune/Inflammation
  • Oncology
  • Diabetes
  • Cardiovascular

Global Clinical Trials Support Services Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • IQVIA Holdings Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PAREXEL International Corporation (a subsidiary of Pamplona Capital Management)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories International Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PRA Health Sciences Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICON Plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Syneos Health Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pharmaceutical Product Development LLC (PPD)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wuxi AppTec Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medpace Holdings Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SGS SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Covance Inc. (a subsidiary of LabCorp)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Celerion Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Clinipace Worldwide
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Worldwide Clinical Trials Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novotech Pty Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MMS Holdings Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Premier Research Group Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medidata Solutions Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Anavex Life Sciences Corp.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cromsource Srl
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments